Results 141 to 150 of about 2,288,892 (269)

The 'Other' face of health security: Reimagining epistemic attachments in global health. [PDF]

PLOS Glob Public Health
López Toledano MD, Alhaffar M, Alshalah A, Saleh M, Durrance-Bagale A, Nunes C, Sharma E, Howard N.   +7 more
europepmc   +1 more source

Global health is our health [PDF]

Nursing Outlook, 2016
openaire   +2 more sources

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

Suicide prevention: keeping the momentum

The Lancet Global Health, 2017
The Lancet Global Health
doaj   +1 more source

Reshaping global health architecture: African health sovereignty as the foundation of global health equity and security. [PDF]

J Public Health Afr
Kaseya J, Dereje N, Benjamin D, Terefe MM, Arega B, Tajudeen R, Fallah MP, Boum Y, Kamenga C, Hall S, Ngongo N.   +10 more
europepmc   +1 more source

ADP‐ribosylation: An emerging regulator of the epigenome

Molecular Oncology, EarlyView.
ADP‐ribosylation has emerged as a dynamic epigenetic signaling mechanism that modifies histones and chromatin‐associated proteins. Through coordinated PARylation and MARylation, it integrates with other histone modifications to regulate chromatin structure, transcription factor activity, and gene expression, influencing genome function and disease ...
Cristel V. Camacho, Chenqian Liu, W. Lee Kraus   +2 more
wiley   +1 more source

An exploratory study on transformational leadership competencies in global health. [PDF]

Front Health Serv
Löfflad-Bürkin BM, Czabanowska K, Vicente-Crespo M, Babich S, Casamitjana N, De Souza LE, Rispel L, Rutebemberwa E, Matthiä A, Okumu F, Kuenzli N, Hoffmann A, Waser M, Kamath R, Ehrenberg JP, Hattendorf J, Bohlius J.   +16 more
europepmc   +1 more source

Castration‐resistant prostate cancer cells are addicted to the high activity of cyclin‐dependent kinase 2

Molecular Oncology, EarlyView.
We show that emergence of castration‐resistant prostate (CRPC) is associated with significant upregulation of cyclins that positively regulate cyclin‐dependent kinase 2 (CDK2) and concomitant downregulation of CDK4 cyclins. This renders CRPC cells dependent on the high activity of CDK2, and CDK2 inhibitors synergistically sensitize CRPC cells to both ...
Joyeeta Chatterjee, Alessia Marin, Shivani Yalala, Harri M. Itkonen   +3 more
wiley   +1 more source

Fighting antimicrobial resistance on all fronts

The Lancet Global Health, 2017
The Lancet Global Health
doaj   +1 more source

Correction to "Ethics of Military Global Health Engagements". [PDF]

Dev World Bioeth
europepmc   +1 more source